Scientists launch global effort to map rare brain disorders
NCT ID NCT07372833
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 150 children and adults worldwide who have a rare genetic condition affecting CAMK2 genes. Researchers will track development, seizures, behavior, and social skills over time. The goal is to create a clear picture of how the disorder progresses, which can help doctors give better care and prepare for future treatment trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study will create detailed maps of how CAMK2 disorders progress, helping doctors predict outcomes and design better treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data only and cannot directly improve symptoms. Results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus MC
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands